165
Pengikut
1
Paparan
127
KEYMED BIOSCIENCES INC
(HKEX: 2162)
Keymed Biosciences, Inc. is an investment holding company, which engages in the discovery and development of biological therapies in the autoimmune and oncology therapeutic areas. It operates through Hong Kong and China geographical segment. The company was founded on April 23, 2018 and is headquartered in Chengdu, China.
63.050 -
-3.000
(-4.54%)
Jarak
62.050 - 66.000
(6.37%)
Buka
66.000
Tutup Terdahulu
66.050
Harga Beli
62.750
Beli Purata
('000)
0.5
Jual Beli
63.050
Purata Jual
('000)
4.5
Purata
('000)
2,871.8
Nilai
181,092,997
Catatan
-
Harga tertunda. Dikemas kini pada 18 May 2026 16:08.
Data dikuasakan oleh
Lihat Semua Acara
165
Loading Chart...
Please login to view stock data and analysis
